BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

659 related articles for article (PubMed ID: 31535225)

  • 21. Management of Patients With Adenocarcinoma or Squamous Cancer of the Esophagus.
    Ilson DH; van Hillegersberg R
    Gastroenterology; 2018 Jan; 154(2):437-451. PubMed ID: 29037469
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Definitive chemoradiotherapy versus neoadjuvant chemoradiotherapy followed by surgery for stage II to III esophageal squamous cell carcinoma.
    Barbetta A; Hsu M; Tan KS; Stefanova D; Herman K; Adusumilli PS; Bains MS; Bott MJ; Isbell JM; Janjigian YY; Ku GY; Park BJ; Wu AJ; Jones DR; Molena D
    J Thorac Cardiovasc Surg; 2018 Jun; 155(6):2710-2721.e3. PubMed ID: 29548582
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Utility of weekly docetaxel combined with preoperative radiotherapy for locally advanced esophageal cancer from pathological analysis.
    Kushida T; Nohara S; Yoshino K; Fujiwara D; Ouchi K; Amano T; Isayama F; Tomita N; Iwanuma Y; Sasai K; Tsurumaru M; Kajiyama Y
    Dis Esophagus; 2014; 27(4):368-73. PubMed ID: 23865505
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A single institutional phase III trial of preoperative chemotherapy with hyperfractionation radiotherapy plus surgery versus surgery alone for resectable esophageal squamous cell carcinoma.
    Lee JL; Park SI; Kim SB; Jung HY; Lee GH; Kim JH; Song HY; Cho KJ; Kim WK; Lee JS; Kim SH; Min YI
    Ann Oncol; 2004 Jun; 15(6):947-54. PubMed ID: 15151953
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Morbidity and Mortality of Patients Who Underwent Minimally Invasive Esophagectomy After Neoadjuvant Chemoradiotherapy vs Neoadjuvant Chemotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma: A Randomized Clinical Trial.
    Wang H; Tang H; Fang Y; Tan L; Yin J; Shen Y; Zeng Z; Zhu J; Hou Y; Du M; Jiao J; Jiang H; Gong L; Li Z; Liu J; Xie D; Li W; Lian C; Zhao Q; Chen C; Zheng B; Liao Y; Li K; Li H; Wu H; Dai L; Chen KN
    JAMA Surg; 2021 May; 156(5):444-451. PubMed ID: 33729467
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chemoradiotherapy versus chemoradiotherapy plus surgery for esophageal cancer.
    Vellayappan BA; Soon YY; Ku GY; Leong CN; Lu JJ; Tey JC
    Cochrane Database Syst Rev; 2017 Aug; 8(8):CD010511. PubMed ID: 28829911
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pretreatment Esophageal Wall Thickness Associated with Response to Chemoradiotherapy in Locally Advanced Esophageal Cancer.
    Wongwaiyut K; Ruangsin S; Laohawiriyakamol S; Leelakiatpaiboon S; Sangthawan D; Sunpaweravong P; Sunpaweravong S
    J Gastrointest Cancer; 2020 Sep; 51(3):947-951. PubMed ID: 31758468
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Radiation dose and pathological response in oesophageal cancer patients treated with neoadjuvant chemoradiotherapy followed by surgery: a multi-institutional analysis.
    Thomas M; Borggreve AS; van Rossum PSN; Perneel C; Moons J; Van Daele E; van Hillegersberg R; Deng W; Pattyn P; Mook S; Boterberg T; Ruurda JP; Nafteux P; Lin SH; Haustermans K
    Acta Oncol; 2019 Oct; 58(10):1358-1365. PubMed ID: 31432736
    [No Abstract]   [Full Text] [Related]  

  • 29. Comparison between radical esophagectomy and definitive chemoradiotherapy in patients with clinical T1bN0M0 esophageal cancer.
    Motoori M; Yano M; Ishihara R; Yamamoto S; Kawaguchi Y; Tanaka K; Kishi K; Miyashiro I; Fujiwara Y; Shingai T; Noura S; Ohue M; Ohigashi H; Nakamura S; Ishikawa O
    Ann Surg Oncol; 2012 Jul; 19(7):2135-41. PubMed ID: 22302264
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term outcome of a phase II study of docetaxel-based multimodality chemoradiotherapy for locally advanced carcinoma of the esophagus or gastroesophageal junction.
    Choong NW; Mauer AM; Haraf DC; Ferguson MK; Sandler AB; Kesler KA; Fishkin PA; Ansari RH; Wade J; Krauss SA; Sciortino DF; Posner MC; Kocherginsky M; Hoffman PC; Szeto L; Vokes EE
    Med Oncol; 2011 Dec; 28 Suppl 1():S152-61. PubMed ID: 20730572
    [TBL] [Abstract][Full Text] [Related]  

  • 31. REG I expression predicts long-term survival among locally advanced thoracic squamous cell esophageal cancer patients treated with neoadjuvant chemoradiotherapy followed by esophagectomy.
    Motoyama S; Sugiyama T; Ueno Y; Okamoto H; Takasawa S; Nanjo H; Watanabe H; Maruyama K; Okuyama M; Ogawa J
    Ann Surg Oncol; 2006 Dec; 13(12):1724-31. PubMed ID: 17009160
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cost-effectiveness of chemoradiation followed by esophagectomy versus chemoradiation alone in squamous cell carcinoma of the esophagus.
    Salcedo J; Suen SC; Bian SX
    Cancer Med; 2020 Jan; 9(2):440-446. PubMed ID: 31749330
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Salvage esophagectomy after definitive chemoradiotherapy for thoracic esophageal cancer.
    Miyata H; Yamasaki M; Takiguchi S; Nakajima K; Fujiwara Y; Nishida T; Mori M; Doki Y
    J Surg Oncol; 2009 Nov; 100(6):442-6. PubMed ID: 19653262
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Feasibility of endoscopic mucosal resection as salvage treatment for patients with local failure after definitive chemoradiotherapy for stage IB, II, and III esophageal squamous cell cancer.
    Makazu M; Kato K; Takisawa H; Yoshinaga S; Oda I; Saito Y; Mayahara H; Ito Y; Itami J; Hamaguchi T; Yamada Y; Shimada Y
    Dis Esophagus; 2014 Jan; 27(1):42-9. PubMed ID: 23442160
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Discussion of the treatment of esophageal carcinoma,especially in the point of non-surgical treatments, from the viewpoint of medical oncology].
    Maeda Y; Sasaki E; Sasaki T
    Gan To Kagaku Ryoho; 2007 Jun; 34(6):831-5. PubMed ID: 17565242
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Endoscopic resection as an independent predictive factor of local control in patients with T1bN0M0 esophageal squamous cell carcinoma treated with chemoradiotherapy: a retrospective study.
    Miyazaki T; Myojin M; Hosokawa M; Aoyama H; Okahara S; Takahashi H
    Radiat Oncol; 2022 Jan; 17(1):11. PubMed ID: 35057830
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment results of neoadjuvant chemoradiotherapy followed by radical esophagectomy in patients with initially inoperable thoracic esophageal cancer.
    Morimoto H; Fujiwara Y; Lee S; Amano K; Hosono M; Miki Y; Osugi H
    Jpn J Radiol; 2018 Jan; 36(1):23-29. PubMed ID: 29080946
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Surgical treatment for esophageal cancer. Current issues.
    Kato H; Fukuchi M; Miyazaki T; Nakajima M; Tanaka N; Inose T; Kimura H; Faried A; Saito K; Sohda M; Fukai Y; Masuda N; Manda R; Ojima H; Tsukada K; Kuwano H
    Dig Surg; 2007; 24(2):88-95. PubMed ID: 17446703
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A history of surgery for locally-advanced (T4) cancer of the thoracic esophagus in Japan and a personal perspective.
    Fujita H
    Ann Thorac Cardiovasc Surg; 2013; 19(6):409-15. PubMed ID: 24284505
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Endoscopic resection with adjuvant chemo-radiotherapy for superficial esophageal squamous cell carcinoma: A critical review.
    Kam TY; Kountouri M; Roth A; Frossard JL; Huber O; Mönig S; Zilli T
    Crit Rev Oncol Hematol; 2018 Apr; 124():61-65. PubMed ID: 29548487
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 33.